North America Pharmaceutical Intermediates Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (GMP and Non GMP), Application (Antibiotics, Antipyretic Analgesics, Vitamins, and Others), and Distribution Channel (Distributor and Direct Sales)

No. of Pages: 115    |    Report Code: TIPRE00025456    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Pharmaceutical Intermediates Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Pharmaceutical Intermediates Market – By Type

1.3.2        North America Pharmaceutical Intermediates Market – By Application

1.3.3        North America Pharmaceutical Intermediates Market – By Distribution Channel

1.3.4        North America Pharmaceutical Intermediates Market– By Country

2.           North America Pharmaceutical Intermediates Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Pharmaceutical Intermediates Market– Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Pharmaceutical Intermediates Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Diseases and Infectious Diseases

5.1.2        Escalating R&D Investments by Pharmaceutical Companies

5.2         Market Restraints

5.2.1        High Price of Manufacturing

5.3         Market Opportunities

5.3.1        Emerging Markets

5.4         Future Trends

5.4.1        Surge in Adoption of AI-based Tools for Drug Discovery

5.5         Impact Analysis

6.           Pharmaceutical Intermediates Market– North America Analysis

6.1         North America Pharmaceutical Intermediates Market Revenue Forecast and Analysis

7.           North America Pharmaceutical Intermediates Market Analysis – By Type

7.1         Overview

7.2         Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

7.3         GMP

7.3.1        Overview

7.3.2        GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Non GMP

7.4.1        Overview

7.4.2        Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.           North America Pharmaceutical Intermediates Market Analysis – By Application

8.1         Overview

8.2         Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

8.3         Antibiotics

8.3.1        Overview

8.3.2        Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Antipyretic Analgesics

8.4.1        Overview

8.4.2        Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Vitamins

8.5.1        Overview

8.5.2        Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.6         Other

8.6.1        Overview

8.6.2        Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.           North America Pharmaceutical Intermediates Market– By Distribution Channel

9.1         Overview

9.2         Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

9.3         Distributor

9.3.1        Overview

9.3.2        Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Direct Sales

9.4.1        Overview

9.4.2        Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

10.        North America Pharmaceutical Intermediates Market – Country Analysis

10.1.1     Overview

10.1.2     North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.1.3     US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1       US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2       US: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.3.3       US: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.3.4       US: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.4     Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1       Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2       Canada: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.4.3       Canada: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.4.4       Canada: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.5     Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1       Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2       Mexico: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.5.3       Mexico: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.5.4       Mexico: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

11.        Impact of COVID-19 Pandemic on North America Pharmaceutical Intermediates Market

11.1      Overview

12.        Pharmaceutical Intermediates Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Pfizer Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Sanofi

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      BASF SE

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Dishman Carbogen Amcis Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Codexis

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Midas Pharma GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      chiracon GmbH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Vertellus Holdings LLC

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8.             Mexico Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             Mexico Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Organic Developments Done By Companies

Table 12.          Inorganic Developments Done By Companies

Table 13.          Glossary of Terms, Pharmaceutical Intermediates Market

LIST OF FIGURES

Figure 1.           North America Pharmaceutical Intermediates Market Segmentation

Figure 2.           North America Pharmaceutical Intermediates Segmentation, By Country

Figure 3.           North America Pharmaceutical Intermediates Market Overview

Figure 4.           GMP Held Largest Share of Type Segment in North America Pharmaceutical Intermediates Market

Figure 5.           US to Show Remarkable Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           North America Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints

Figure 9.           North America Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        North America Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

Figure 11.        North America GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

Figure 14.        North America Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        North America Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

Figure 19.        North America Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 22.        North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 23.        US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic in North American Country Markets

The List of Companies - North America Pharmaceutical Intermediates Market

  1. BASF SE
  2. chiracon GmbH
  3. Codexis
  4. Dishman Carbogen Amcis Ltd
  5. Midas Pharma GmbH
  6. Pfizer Inc.
  7. Sanofi
  8. Vertellus Holdings LLC